Követés
András Tálas
András Tálas
E-mail megerősítve itt: uzh.ch - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage
PI Kulcsár, A Tálas, K Huszár, Z Ligeti, E Tóth, N Weinhardt, E Fodor, ...
Genome biology 18, 1-17, 2017
1372017
Improved LbCas12a variants with altered PAM specificities further broaden the genome targeting range of Cas12a nucleases
E Toth, E Varga, PI Kulcsár, V Kocsis-Jutka, SL Krausz, A Nyeste, ...
Nucleic acids research 48 (7), 3722-3733, 2020
932020
Mb-and FnCpf1 nucleases are active in mammalian cells: activities and PAM preferences of four wild-type Cpf1 nucleases and of their altered PAM specificity variants
E Tóth, BC Czene, PI Kulcsár, SL Krausz, A Tálas, A Nyeste, É Varga, ...
Nucleic acids research 46 (19), 10272-10285, 2018
642018
Cpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells
E Tóth, N Weinhardt, P Bencsura, K Huszár, PI Kulcsár, A Tálas, E Fodor, ...
Biology direct 11, 1-14, 2016
642016
Blackjack mutations improve the on-target activities of increased fidelity variants of SpCas9 with 5′ G-extended sgRNAs
PI Kulcsár, A Tálas, E Tóth, A Nyeste, Z Ligeti, Z Welker, E Welker
Nature communications 11 (1), 1223, 2020
392020
A convenient method to pre-screen candidate guide RNAs for CRISPR/Cas9 gene editing by NHEJ-mediated integration of a ‘self-cleaving’GFP-expression plasmid
A Tálas, PI Kulcsár, N Weinhardt, A Borsy, E Tóth, K Szebenyi, SL Krausz, ...
DNA Research 24 (6), 609-621, 2017
272017
PEAR, a flexible fluorescent reporter for the identification and enrichment of successfully prime edited cells
DA Simon, A Tálas, PI Kulcsár, Z Biczók, SL Krausz, G Várady, E Welker
Elife 11, e69504, 2022
252022
SuperFi-Cas9 exhibits remarkable fidelity but severely reduced activity yet works effectively with ABE8e
PI Kulcsár, A Tálas, Z Ligeti, SL Krausz, E Welker
Nature Communications 13 (1), 6858, 2022
24*2022
BEAR reveals that increased fidelity variants can successfully reduce the mismatch tolerance of adenine but not cytosine base editors
A Tálas, DA Simon, PI Kulcsár, É Varga, SL Krausz, E Welker
Nature communications 12 (1), 6353, 2021
162021
A method for characterizing Cas9 variants via a one-million target sequence library of self-targeting sgRNAs
A Tálas, K Huszár, PI Kulcsár, JK Varga, É Varga, E Tóth, Z Welker, ...
Nucleic Acids Research 49 (6), e31-e31, 2021
122021
Identification of new interactions between endolysosomal tethering factors
Z Simon-Vecsei, Á Sőth, P Lőrincz, A Rubics, A Tálas, PI Kulcsár, ...
Journal of Molecular Biology 433 (13), 166965, 2021
32021
Position-dependent sequence motif preferences of SpCas9 are largely determined by scaffold-complementary spacer motifs
K Huszár, Z Welker, Z Györgypál, E Tóth, Z Ligeti, PI Kulcsár, J Dancsó, ...
Nucleic Acids Research 51 (11), 5847-5863, 2023
22023
Predicting prime editing efficiency across diverse edit types and chromatin contexts with machine learning
N Mathis, A Allam, A Tálas, E Benvenuto, R Schep, T Damodharan, ...
bioRxiv, 2023.10. 09.561414, 2023
22023
Treatment of a genetic liver disease in mice through transient prime editor expression
T Rothgangl, EI Ioannidi, Y Weber, A Talas, D Boeck, M Matsushita, ...
bioRxiv, 2024.01. 22.575834, 2024
12024
A cleavage rule for selection of increased-fidelity SpCas9 variants with high efficiency and no detectable off-targets
PI Kulcsár, A Tálas, Z Ligeti, E Tóth, Z Rakvács, Z Bartos, SL Krausz, ...
Nature Communications 14 (1), 5746, 2023
12023
Target-matched increased fidelity SpCas9 variants can edit any target without genome-wide off-target effects
PI Kulcsár, A Tálas, Z Ligeti, E Tóth, Z Rakvács, VL Végi, SL Krausz, ...
bioRxiv, 2022.08. 16.504097, 2022
12022
Variant cas9
E Welker, P Kulcsár, A Tálas, T Eszter, Z Ligeti, A Nyeste, Z Welker
US Patent App. 17/781,452, 2023
2023
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–17